Ligand Pharmaceuticals
LGND
#2827
Rank
โ‚น535.39 B
Marketcap
โ‚น26,766
Share price
-3.94%
Change (1 day)
46.80%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2026 (TTM): โ‚น233.67

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น241.60. In 2025 the company made an earnings per share (EPS) of โ‚น587.66 an increase over its 2024 EPS that were of -โ‚น4.66.

EPS history for Ligand Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น233.67-60.24%
2025โ‚น587.66-12700%
2024-โ‚น4.66-101.73%
2023โ‚น269.58-245.96%
2022-โ‚น184.69-157.23%
2021โ‚น322.75-2571.43%
2020-โ‚น13.06-100.46%
2019โ‚น2,855353.48%
2018โ‚น629.641025%
2017โ‚น55.97-700%
2016-โ‚น9.33-100.87%
2015โ‚น1,0781859.32%
2014โ‚น55.045.36%
2013โ‚น52.248.0704505322479E+18%
2012โ‚น0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น623.09 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น66.23-72.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,881 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,621 571.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น131.52-154.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.63-61.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น421.63 74.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น268.40 11.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-โ‚น33.58-113.90%๐Ÿ‡บ๐Ÿ‡ธ USA